Kerafast
Boston, US · Founded 2010 · Delaware corporation · 1 known investors
Kerafast operates an online platform that sells unique laboratory-made research reagents — including cell lines, antibodies, small molecules, and dyes — sourced from academic and research labs worldwide. It handles selling and shipping logistics for providing labs (which receive royalties) and gives procuring scientists access to reagents often unavailable elsewhere, bypassing the traditional Material Transfer Agreement process.
B2B MarketplacesBiotechE-commerce
Founders & leadership
AB
Andrew BouldinDirector
KD
Kim D WestmorelandDirector
WE
William EmhiserDirector
JR
Jennifer RossiExecutive Officer
MA
Matthew A KingDirector
RP
Robert P BondarykExecutive Officer, Director
Investors · 1
Reported raises · per SEC filings
Form D private placements▶$250KraisedMar 2016 · 1 investors · OtherRule 506(c)
▶$250KraisedMar 2016 · 1 investors · Other
Rule 506(c)Officers, directors & promoters on the filing
- Kim WestmorelandDirector
- Robert P BondarykExecutive Officer, Director
- Andrew BouldinDirector
- William EmhiserDirector
- Matthew KingDirector
- Offering amount
- $1.1M
- Amount sold
- $250K
- First sale
- Mar 2016
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06c
▶$634.8KraisedApr 2015 · 11 investors · OtherRule 506(b)
▶$634.8KraisedApr 2015 · 11 investors · Other
Rule 506(b)Officers, directors & promoters on the filing
- Andrew BouldinDirector
- Kim D WestmorelandDirector
- William EmhiserDirector
- Jennifer RossiExecutive Officer
- Matthew A KingDirector
- Robert P BondarykExecutive Officer, Director
- Offering amount
- $1M
- Amount sold
- $634.8K
- First sale
- Oct 2014
- Incorporated
- Corporation, Delaware, 2010
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.